Header graphic for print
Focus on Regulation

Tag Archives: marketing authorisation

The European Medicines Agency adopts new guidance on Adaptive Pathways

The European Medicines Agency (“EMA”) has published a new guidance document for companies that wish to participate in the Adaptive Pathways initiative (“New Guidance”). Adaptive Pathways Adaptive Pathways was established as part of the EMA’s objective to improve timely access for patients to new medicinal products. Adaptive Pathways applies to medicinal products with the potential